Australia expands access to bone mineral density testing:
This article was originally published in Clinica
Australia has expanded public insurance subsidies to cover bone mineral density testing for all people aged 70 years and over. Previously, subsidised testing was available only for patients with proven low bone mineral density or who are considered at high-risk. The expansion is expected to cost Aus$135m (US$110.5m), from April 1 2007 to June 30 2011. In 2005-2006, more than 53,000 patients aged 70 years and over received subsidised testing. It is expected that in 2007-08 326,000 new patients will be tested and that this number will increase to more than 360,000 in 2010-11.
You may also be interested in...
Sandoz announced more than a year ago that its GP2411 biosimilar denosumab candidate had entered the clinic. Management provided an update on its progress at the recent Virtual Meet Novartis Management Investor Event.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.